Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1994;74:1009-1013

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weglicki, W. B.
Right arrow Articles by Phillips, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weglicki, W. B.
Right arrow Articles by Phillips, T. M.

Circulation Research, Vol 74, 1009-1013, Copyright © 1994 by American Heart Association


ARTICLES

Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition

WB Weglicki, IT Mak and TM Phillips
Department of Medicine, George Washington University Medical Center, Washington, DC 20037.

In previous work we reported the elevation of circulating inflammatory cytokines in rodents maintained on a Mg(2+)-deficient diet. Within the first week of Mg2+ deficiency, significant elevation of the neuropeptides substance P (SP) and calcitonin gene-related peptide (CGRP) occurs. The present study was designed to assess the effects of SP receptor blockade by CP-96,945 and its inactive enantiomer CP-96,344 on tissue cytokine levels and in vivo oxidative indexes. CP-96,345 had no significant effect on circulating levels of SP or CGRP; however, at the tissue level, a significant decrease (P < .01) in myocardial accumulation of SP occurred; the inactive enantiomer was only slightly effective. In addition, CP-96,345 significantly reduced (by 53%) the accumulation of tumor necrosis factor-alpha (TNF-alpha) (but not interleukin-1 and interleukin-6) within the lesions; the effect of the enantiomer was insignificant. We conclude that treatment with CP-96,345 inhibits SP and TNF-alpha tissue levels in cardiac lesions, indicating a linkage between this neuropeptide and TNF-alpha. Both SP and TNF- alpha can trigger free radical production; plasma thiobarbituric acid- reactive materials were elevated 2.5-fold and red blood cell reduced glutathione was reduced 55% during Mg2+ deficiency. In the presence of CP-96,345, both indexes of in vivo oxidation were significantly attenuated; the enantiomer was ineffective. These latter observations point to a neuropeptide/TNF-alpha/free radical-triggered mechanism that may be the major pathway of systemic oxidative injury inducing the cardiomyopathic lesions seen during Mg2+ deficiency.


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. T. Weber, W. B. Weglicki, and R. U. Simpson
Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium
Cardiovasc Res, February 15, 2009; 81(3): 500 - 508.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
M Rodriguez-Moran and F Guerrero-Romero
Serum magnesium and C-reactive protein levels
Arch. Dis. Child., August 1, 2008; 93(8): 676 - 680.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Sapna, S. K. Ranjith, and K. Shivakumar
Cardiac fibrogenesis in magnesium deficiency: a role for circulating angiotensin II and aldosterone
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H436 - H440.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. Ahokas, Y. Sun, S. K. Bhattacharya, I. C. Gerling, and K. T. Weber
Aldosteronism and a Proinflammatory Vascular Phenotype: Role of Mg2+, Ca2+, and H2O2 in Peripheral Blood Mononuclear Cells
Circulation, January 4, 2005; 111(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. I. Tejero-Taldo, J. J. Chmielinska, G. Gonzalez, I. T. Mak, and W. B. Weglicki
N-Methyl-D-aspartate Receptor Blockade Inhibits Cardiac Inflammation in the Mg2+-Deficient Rat
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 8 - 13.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Ahokas, K. J. Warrington, I. C. Gerling, Y. Sun, L. A. Wodi, P. A. Herring, L. Lu, S. K. Bhattacharya, A. E. Postlethwaite, and K. T. Weber
Aldosteronism and Peripheral Blood Mononuclear Cell Activation: A Neuroendocrine-Immune Interface
Circ. Res., November 14, 2003; 93 (10): e124 - e135.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
K. T Weber, Yao Sun, L. A Wodi, A. Munir, E. Jahangir, R. A Ahokas, I. C Gerling, A. E Postlethwaite, and K. J Warrington
Toward a broader understanding of aldosterone in congestive heart failure
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 155 - 163.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. C. Gerling, Y. Sun, R. A. Ahokas, L. A. Wodi, S. K. Bhattacharya, K. J. Warrington, A. E. Postlethwaite, and K. T. Weber
Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H813 - H821.
[Abstract] [Full Text] [PDF]